News

Foamix news releases

Stay up-to-date on the latest news and innovation from Foamix

Foamix Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Foamix Submits New Drug Application to U.S. FDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular Rosacea

Foamix Announces $64 Million Capital Financing Investment by Perceptive Advisors and OrbiMed